Cat.#: ACPP-1719
| Despition | FDFT1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
| ACPP-1567 | Human EFNB2 Protein (AC1567) | 5 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1303 | Human Stratifin Protein (AC1303) | 5 µg | inquiry |
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
| ACPP-1768 | Human SNAP25 Protein (AC1768) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.